FBW7 serves as a tumor suppressor in CRC, it has been reported that FBW7 mutations [40, 41] and low expression [42, 43, 44, 45] are strongly positively associated with poor prognosis in CRC patients. This evidence concerns the gene FBXW7 and colorectal carcinoma.